Xizang Haisco Pharmaceutical Group Co Ltd (002653)

Shenzhen
Currency in CNY
36.96
+1.49(+4.20%)
Closed
002653 Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
35.1637.58
52 wk Range
25.1340.66
Key Statistics
Edit
Bid/Ask
36.83 / 36.83
Prev. Close
35.47
Open
35.16
Day's Range
35.16-37.58
52 wk Range
25.13-40.66
Volume
5.6M
Average Volume (3m)
4.4M
1-Year Change
33.36%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002653 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
42.38
Upside
+14.66%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
No news in this category
Looks like there are no results in this news category

Xizang Haisco Pharmaceutical Group Co Ltd Company Profile

Haisco Pharmaceutical Group Co., Ltd. research, develops, manufactures, and sells pharmaceuticals in China. The company offers cycloporol, dolasetron mesylate, polyene phosphatidylcholine, compound amino acid, and methylprednisolone sodium injections, as well as flupenthixol melitracen tablets. It offers its products in various therapeutic fields, including anesthesia, parenteral nutrition, tumor antiemetic, liver, gallbladder digestion, antibiotics, cardiovascular, and cerebrovascular. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Shannan, China.

Employees
5448
Market
China

Compare 002653 to Peers and Sector

Metrics to compare
002653
Peers
Sector
Relationship
P/E Ratio
82.6x26.2x−0.5x
PEG Ratio
3.22−0.620.00
Price/Book
9.4x1.8x2.6x
Price / LTM Sales
10.6x2.9x3.0x
Upside (Analyst Target)
19.5%16.1%53.8%
Fair Value Upside
Unlock7.3%9.2%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 42.38
(+14.66% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.43%
Dividend Yield
1.35%
Industry Median 1.40%
Annualised payout
0.48
Paid unevenly
5-Years Growth
+20.36%
Growth Streak

Earnings

Latest Release
Oct 30, 2024
EPS / Forecast
-- / --
Revenue / Forecast
1.06B / 1.07B
EPS Revisions
Last 90 days

FAQ

What Is the Xizang Haisco Pharmaceutical A (002653) Stock Price Today?

The Xizang Haisco Pharmaceutical A stock price today is 36.96

What Stock Exchange Does Xizang Haisco Pharmaceutical A Trade On?

Xizang Haisco Pharmaceutical A is listed and trades on the Shenzhen stock exchange.

What Is the Stock Symbol for Xizang Haisco Pharmaceutical A?

The stock symbol for Xizang Haisco Pharmaceutical A is "002653."

Does Xizang Haisco Pharmaceutical A Pay Dividends? What’s The Current Dividend Yield?

The Xizang Haisco Pharmaceutical A dividend yield is 1.35%.

What Is the Xizang Haisco Pharmaceutical A Market Cap?

As of today, Xizang Haisco Pharmaceutical A market cap is 41.01B.

What is Xizang Haisco Pharmaceutical A Earnings Per Share?

The Xizang Haisco Pharmaceutical A EPS is 0.432.

What Is the Next Xizang Haisco Pharmaceutical A Earnings Date?

Xizang Haisco Pharmaceutical A will release its next earnings report on 15 Apr 2025.

From a Technical Analysis Perspective, Is 002653 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.